Taiwan FDA registration 1bdd407add9d0300b03c0b30f874a690
DIAVUE ToGo Blood Glucose Test Strip
TW: 糖悠妥顧血糖試片
Taiwan·Risk Class 2·MD·Taibo Technology Co., Ltd. five-stock factory·Registered Jan 23, 2019 – Jan 23, 2024ExpiredRegistration details
- Analysis ID
- 1bdd407add9d0300b03c0b30f874a690
- License Form
- Ministry of Health Medical Device Manufacturing No. 006280
Company information
- Manufacturer
- Taibo Technology Co., Ltd. five-stock factory
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- BIOCARE CORPORATION
Product details
- Intended Use
- This product is an in vitro diagnostic medical device, which can quantitatively detect the glucose content in fresh microvascular whole blood. It is suitable for self-measurement and blood glucose monitoring in diabetic patients.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jan 23, 2019
- Expiry Date
- Jan 23, 2024
About this record
Access comprehensive regulatory information for DIAVUE ToGo Blood Glucose Test Strip in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1bdd407add9d0300b03c0b30f874a690 and manufactured by Taibo Technology Co., Ltd. five-stock factory. The authorized representative in Taiwan is BIOCARE CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices